1. Home
  2. RWAY vs SGHT Comparison

RWAY vs SGHT Comparison

Compare RWAY & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Runway Growth Finance Corp.

RWAY

Runway Growth Finance Corp.

HOLD

Current Price

$6.69

Market Cap

284.1M

Sector

N/A

ML Signal

HOLD

Logo Sight Sciences Inc.

SGHT

Sight Sciences Inc.

HOLD

Current Price

$8.27

Market Cap

309.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RWAY
SGHT
Founded
2015
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
284.1M
309.6M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
RWAY
SGHT
Price
$6.69
$8.27
Analyst Decision
Buy
Buy
Analyst Count
6
7
Target Price
$9.50
$9.08
AVG Volume (30 Days)
587.0K
251.2K
Earning Date
05-07-2026
05-06-2026
Dividend Yield
21.54%
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
$77,363,000.00
Revenue This Year
$1.26
$11.67
Revenue Next Year
$1.25
$10.39
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.19
$3.19
52 Week High
$10.92
$9.24

Technical Indicators

Market Signals
Indicator
RWAY
SGHT
Relative Strength Index (RSI) 62.23 81.54
Support Level $6.43 $8.00
Resistance Level $6.88 $8.93
Average True Range (ATR) 0.20 0.52
MACD 0.08 0.22
Stochastic Oscillator 81.01 91.27

Price Performance

Historical Comparison
RWAY
SGHT

About RWAY Runway Growth Finance Corp.

Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States. The company's investment objective is to maximize its total return to its stockholders through current income on its loan portfolio, and secondarily through capital gain on its warrants and other equity positions.

About SGHT Sight Sciences Inc.

Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The company operates through two segments: Interventional Glaucoma, which generates the majority of revenue and includes the OMNI Surgical System family of products and the SION Surgical Instrument used in minimally invasive glaucoma surgery to reduce intraocular pressure in adult patients with open-angle glaucoma; and Interventional Dry Eye, which includes the TearCare System, an interventional device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality in adult patients with evaporative dry eye disease.

Share on Social Networks: